# Assessing Brain Metabolism Using MRS With Deuterated Glucose

> **NCT06594315** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 80 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** Deuterated Glucose
- **PROCEDURE:** Magnetic Resonance Imaging (MRI)
- **PROCEDURE:** Blood Sample
- **PROCEDURE:** MR spectroscopy (MRS)

## Key facts

- **NCT ID:** NCT06594315
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-20
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06594315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06594315, "Assessing Brain Metabolism Using MRS With Deuterated Glucose". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06594315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*